Chewy (CHWY) Could Be 34% Undervalued Following Russell 2500 Inclusion

Chewy

Chewy

CHWY

0.00

Why Chewy’s Index Additions Matter for Investors

Chewy (CHWY) is drawing fresh interest after being added to the Russell 2500 Index and Russell 2500 Growth Benchmark, a shift that can influence institutional ownership and trading activity.

This index inclusion arrives alongside recent analyst attention, a new seven year senior secured term loan facility, and first quarter results that featured revenue and earnings growth with expanding profitability, giving investors several new data points to weigh.

Despite the fresh attention from index additions and analyst commentary, Chewy’s 1 year total shareholder return is down 47.21% and the 5 year total shareholder return is down 73.95%. The 90 day share price return is down 20.92%, suggesting recent momentum has been weak.

If you are weighing Chewy against other opportunities, this could be a useful moment to see how a focused screener of robotics and automation related stocks compares, starting with 30 robotics and automation stocks.

Chewy trades at a steep discount to analyst targets and an even larger gap to some fair value estimates. Yet the stock still carries a premium to sector P/E checks and recent returns are weak, so is the caution justified?

Most Popular Narrative: 33.8% Undervalued

Chewy's most followed narrative pegs fair value at $31.05 a share compared with the recent $20.56 close, setting up a wide valuation gap for investors to assess.

Chewy's strategic expansions, such as opening new Chewy Vet Care Clinics, are expected to further penetrate the $25 billion vet services market, likely increasing revenue and active customer engagement in 2025 and beyond.

Read the complete narrative. Read the complete narrative.

Want to understand why this narrative leans into pet health and advertising as key levers? The projected mix of recurring revenue, margin lift and future earnings power sits at the core of that $31.05 figure. The underlying assumptions may surprise you once you see how growth, profitability and required returns are stitched together.

Result: Fair Value of $31.05 (UNDERVALUED)

However, Chewy’s heavy reliance on Autoship for over 80% of sales, along with slower customer growth, could quickly challenge this undervalued narrative if those trends weaken.

Another View on Chewy’s Valuation

The popular Chewy narrative leans on a fair value of $31.05, but the market is also putting a clear price on current earnings. Chewy trades on a P/E of 33x, compared with a US Specialty Retail industry average of 19.9x, peer average of 14.7x and a fair ratio of 23.1x.

The difference suggests investors are paying a higher price than both peers and the fair ratio that the market could eventually move toward. This can raise the risk of disappointment if growth or margins do not match expectations. How comfortable are you paying a premium price where other investors see a discount story?

NYSE:CHWY P/E Ratio as at Jul 2026
NYSE:CHWY P/E Ratio as at Jul 2026

Next Steps

If the mixed sentiment on Chewy has you thinking, review the data to evaluate both sides of the story and weigh the 2 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Chewy?

Chewy may have your attention, but your next strong opportunity could be sitting elsewhere. Do not leave it to chance when targeted stock lists are a few clicks away.

  • Target potential value by scanning companies that combine quality fundamentals with appealing valuations through the 44 high quality undervalued stocks.
  • Strengthen your defense by focusing on companies with healthier balance sheets and resilient financial profiles using the solid balance sheet and fundamentals stocks screener (47 results).
  • Hunt for overlooked opportunities by reviewing our screener containing 19 high quality undiscovered gems before other investors catch on.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.